|1.||Treglia, Giorgio: 51 articles (10/2015 - 10/2011)|
|2.||Kumar, Rakesh: 44 articles (01/2016 - 11/2004)|
|3.||Rubello, Domenico: 34 articles (01/2016 - 10/2004)|
|4.||Alavi, Abass: 33 articles (12/2015 - 07/2002)|
|5.||Sharma, Punit: 32 articles (10/2015 - 09/2011)|
|6.||Choi, Joon Young: 30 articles (09/2015 - 11/2004)|
|7.||Giovanella, Luca: 29 articles (10/2015 - 08/2007)|
|8.||Bal, Chandrasekhar: 25 articles (10/2015 - 05/2012)|
|9.||Fanti, Stefano: 25 articles (10/2015 - 04/2004)|
|10.||Kim, Byung-Tae: 25 articles (01/2015 - 06/2003)|
01/01/2011 - "Positron emission tomography (PET)/CT with 18F-FDG has proven to be effective in detecting and assessing various types of cancers. "
09/01/2010 - "18F-FDG has proved to be useful as indicator of tumor aggressiveness rather than detection of extent of disease, and 68Ga-DOTA-TOC has demonstrated good results in clinical trials. "
09/01/2010 - "Imaging using both 18F-FETNIM and 18F-FDG appears to be beneficial in the evaluation of solid tumors. "
01/01/2008 - "The diagnostic accuracy of 18F-FDG PET/CT was shown to be nearly equal to ultrasound, and considering their limited sensitivities, the high radiation exposure by 18F-FDG PET/CT and also costs of the examination, it is likely that AUS will be more cost-effective in detecting massive axillary tumor burden. "
05/01/1997 - "With MMC and CDDP, size reduction became significant on Days 8 or 11, whereas 18F-FDG tumor uptake had already been decreased on Days 3 or 7. Fluorine-18-FDG uptake decreases in parallel to the efficacy of anticancer agents and correlates with subsequent morphologic changes. "
|2.||Neoplasm Metastasis (Metastasis)
01/01/2013 - "Our data allow the conclusion that 18F-FDG PET/CT is superior to planar bone scintigraphy, CT or 18F-FDG PET in detecting bone metastasis. "
05/01/2005 - "18F-FDG PET is superior to MRI in identifying lower neck nodal metastasis of NPC. "
05/01/2003 - "Whenever 18F-FDG PET and LAG are performed in the same patient to assess the extent of lymph-node metastases, LAG should always be done after the 18F-FDG PET study to obviate false-positive results."
04/01/2015 - "The addition of tailored liver-specific 18F-FDG PET/CT protocols (PL-PET and RGL-PET) to a WB-PET, improved the detection of intrahepatic colorectal metastases, compared to WB-PET alone. "
01/01/2015 - "Aim of this study was to investigate the potential of 18F-FDG PET, diffusion weighted imaging (DWI) and susceptibility-weighted (T2*) MRI to predict response to systemic treatment in patients with colorectal liver metastases. "
|3.||Breast Neoplasms (Breast Cancer)
01/01/2015 - "Thirty-three breast cancer patients, who underwent both 18F-FES and 18F-FDG PET/CT from July 2010 to March 2013 in our center, were enrolled in this preliminary study. "
10/01/2013 - "The aim of the present study was to evaluate the relevance of breast cancer subtypes for monitoring of therapy response during NAC with 18F-FDG PET/CT. "
08/01/2012 - "The purpose of the study was to assess the comparison of 18F-FDG PET/CT and CT in patients with breast cancer (BC) already treated with primary therapy, in evaluating the diagnostic and prognostic values. "
03/01/2007 - "The aim of this study is to assess the diagnostic value of positron emission tomography (PET) utilizing [18F]2-fluoro-2-deoxy-D-glucose (FDG) in the axillary staging of breast cancer. "
06/01/2004 - "In this review the findings of response monitoring studies in breast cancer, using [(18)F]2-fluoro-2-deoxy-D-glucose (FDG) and positron emission tomography (PET), are summarised. "
10/01/2004 - "We hypothesized that delineation of gliomas from gray matter with 18F-FDG PET could be improved by extending the interval between 18F-FDG administration and PET data acquisition. "
09/01/1997 - "PET with 11C-MET and 18F-FDG may help to evaluate, in vivo, the metabolic heterogeneity of human gliomas. "
07/01/2013 - "In this study, we investigated the utility of 13N-ammonia in the evaluation of untreated gliomas and compared the results with that of 18F-FDG. "
07/01/2013 - "The aim of this study was to validate 18F-FDG PET imaging for differentiating high-grade gliomas (HGGs) from low-grade gliomas (LGGs). "
07/01/2013 - "Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study."
|5.||Lung Neoplasms (Lung Cancer)
06/01/2015 - "Optimal Scan Time of 18F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report."
01/01/2015 - "The objective of this study was to assess incidental 18F-FDG uptake by the gastrointestinal tract (GIT) in patients with lung cancer. "
01/01/2013 - "Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study."
01/01/2012 - "Although a histopathological examination by bronchoscopic study could not reveal the malignancy, lung cancer was mostly suspected after the results of a chest computed tomography and [18F]-fluorodeoxyglucose positron emission tomography. "
01/01/2012 - "The purpose of this study was to examine the clinical feasibility of CT versus integrated [18F]fluorodeoxyglucose-positron emission tomography (PET)/low-dose CT scan in patients with suspected lung cancer and pulmonary lesions on CT. "
|2.||Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
|6.||Blood Glucose (Blood Sugar)
|7.||Biological Markers (Surrogate Marker)
|8.||Biological Tumor Markers (Tumor Markers)
|9.||methionine methyl ester
|1.||Drug Therapy (Chemotherapy)
|3.||Heterologous Transplantation (Xenotransplantation)